Analytical Data
-
Gene name
MRPS22
- Application
-
Alternative Names
28S ribosomal protein S22; C3orf5; COXPD5; GIBT; GK002; mitochondrial; Mitochondrial ribosomal protein S22; MRP-S22; MRPS22; RPM S22; RPMS22; RT22_HUMAN; S22mt
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P82650
-
Expression Region
1-360aa
-
Molecular Weight
68.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MRPS22, a gene encoding a mitochondrial ribosomal protein, plays a critical role in mitochondrial function and protein synthesis. Variations or mutations in MRPS22 have been associated with various mitochondrial disorders, highlighting its importance in cellular metabolism and energy production. The study of MRPS22 recombinant protein is essential for understanding the molecular mechanisms underlying these disorders. By producing and characterizing MRPS22 as a recombinant protein, researchers can investigate its structural and functional properties in detail. This research not only aids in elucidating the role of MRPS22 in mitochondrial ribosome assembly but also provides insights into the complex interplay between mitochondrial dysfunction and metabolic diseases. Furthermore, recombinant MRPS22 can serve as a valuable tool for developing therapeutic strategies aimed at ameliorating the impacts of MRPS22-related pathologies, thus contributing to advancements in personalized medicine and targeted treatments for mitochondrial diseases. As such, the exploration of MRPS22 through recombinant technology is a pivotal step toward unraveling the intricacies of mitochondrial biology and its implications for human health.
